2008: Miscellaneous Rheumatic and Inflammatory Diseases I
Search or Browse by Day

Miscellaneous Rheumatic and Inflammatory Diseases I

Monday, October 27, 2008
823
Comparison Of Employable Life-Years In Patients With Rheumatoid Arthritis Treated With Infliximab Plus Methotrexate Or Methotrexate Alone: A Preliminary Analysis Using A Markov Model
824
Golimumab Significantly Reduces Time Lost from Work for Patients with Rheumatoid Arthritis: Pooled Results from Three Phase 3 Studies
825
Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis: An Update Systematic Review and Metaanalysis
826
Efficacy and Toxicity of Methotrexate Combination vs. Monotherapy Therapy in Rheumatoid Arthritis: An updated systematic review and metaanalysis
827
Antimalarials safety: a 17 years follow-up study
828
Diagnostic Utility Of Anti-citrullinated Vimentin Antibodies In Daily Practice
829
Baseline Predictors Of Persistent Arthritis In Anti-cyclic Citrullinated Protein/Rheumatoid Factor Negative Very Early Arthritis Patients
830
Tumor Necrosis Factor alpha Antagonists in the Treatment of Secondary Amyloidosis
831
Diagnostic Performance of Measuring Free Light Chains in Fat Tissue of Patients with AL Amyloidosis
832
Diagnostic Performance of Transthyretin Quantification in Fat Tissue of Patients with ATTR Amyloidosis
833
Distressed Personality Traits are Associated With Higher Pro-Inflammatory Cytokine Levels in Patients With Either Scleroderma or Sarcoidosis
834
Sarcoid-like Granulomatosis In Patients Treated With Tnf Blockers : A Series Of 10 Cases
835
TNF Inhibition as Novel Therapy for Refractory Sarcoidosis: Long Term Follow Up
836
Genotypic-phenotypic Correlations in a T50M TRAPS Family from Galway, Ireland
837
Follow-up of an Irish Family with TNF Receptor Associated Periodic Syndrome (TRAPS) with T50M mutation and Disappointing Results with Etanercept Therapy
838
Therapeutic Options for Mouse Amyloidogenesis; from NSAIDs to cyclophosphamide
839
Characterization of Familial Mediterranean Fever in Ashkenazi Jews
840
Subclinical Atherosclerosis in Familial Mediterranean Fever
841
Adjusted Level Of Ferritin Could Predict The Development Of Chronic Pattern In Patients With Adult Onset Still's Disease
842
The Usefulness of 18F-FDG PET in the Assessment of Adult onset Still Disease
843
Increased Serum Heme Oxygenase 1 and IL-18 Levels are Associated with Skin Manifestations in Adult Still’s Disease and Atopic Dermatitis
844
Serum Calprotectin as a Useful Indicator of Disease Activity and Severity in Adult-Onset Still’s Disease
845
Cytomegalovirus Infection In Patients With Connective Tissue Diseases Receiving Immunosuppressive Therapy
846
Clinical Characteristics of Cytomegalovirus Infection in Patients with Connective Tissue Diseases
847
Analysis Of The Efficacy Of Infliximab On Refractory Non-infectious Posterior Uveitis
848
Rituximab Therapy For Refractory Systemic-onset Juvenile Idiopathic Arthritis
849
The Pharmacokinetics (PK) of Single- and Multiple-Dose Anakinra in Patients with Neonatal-Onset Multisystem Inflammatory Disease (NOMID/CINCA)
850
A Strategy For Preventing TB Infection (TBI) Among Patients With Inflammatory Rheumatic Diseases (IRD) Receiving Anti-TNF-α (TNFi) Treatment
See more of: ACR Abstract Submission Poster Sessions
<< Previous Session Level | Next Session Level >>